TP53 and neoplasm: Importantly, combination treatment by targeted system proved to be most effective in tumor growth inhibition compared to individual wt-p53 gene (Figure 1a) or gemcitabine (Figure 4a) treatment using same delivery system (50.1 and 61.7% respectively).